This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality. Issue 2 (1st May 2010)
Record Type:
Journal Article
Title:
Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality. Issue 2 (1st May 2010)
Main Title:
Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality
Abstract : Commentary on: Sharma M Ansari MT Abou-Setta AM . Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia . Ann Intern Med 2009 ;151 :622 –30 .